Page 1 of 9
Sort by: Relevance | Date
This article is part of a Supplement: Volume 69 Supplement 1
This article is part of a Supplement: Volume 68 Supplement 1
The Correction to this article has been published in The Journal of Physiological Sciences 2018 69:s12576-018-0633-5
The Correction to this article has been published in The Journal of Physiological Sciences 2018 69:s12576-018-0624-6
This article is part of a Supplement: Volume 2017 Supplement 1
This article is part of a Supplement: Volume 71 Supplement 1
This article is part of a Supplement: Volume 64 Supplement 1
This article is part of a Supplement: Volume 59 Supplement 1
This article is part of a Supplement: Volume 65 Supplement 1
This article is part of a Supplement: Volume 65 Supplement 1
This article is part of a Supplement: Volume 1 Supplement 3
This article is part of a Supplement: Volume 65 Supplement 1
As a response to the recent article by Hifumi et al. published in the Journal of Intensive Care, the present correspondence clarifies the family-level taxonomy of the yamakagashi (Rhabdophis tigrinus). Further, t...
This article is part of a Supplement: Volume 12 Supplement 1
This article is part of a Supplement: Volume 7 Supplement 1
This article is part of a Supplement: Volume 65 Supplement 1
The editors of Journal of Physiological Anthropology would like to thank all our reviewers who have contributed to the journal in Volume 34 (2015).
This article is part of a Supplement: Volume 63 Supplement 1
Although anaplastic lymphoma kinase (ALK) fusion genes are generally identified in lung adenocarcinoma patients, they are relatively rare in patients with squamous cell carcinoma (SqCC). Metastatic ALK-rearranged...
In the original publication of this article [1], the figure legends of Fig. 2 and Fig. 3 are wrong and should be changed as below:
The Publisher Correction to this article has been published in Journal of Intensive Care 2019 7:43
The original article was published in Journal of Intensive Care 2019 7:27
This article is part of a Supplement: Volume 15 Supplement 2
Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is currently used to achieve glycemic targets in patients with type 2 diabetes mellitus (T2DM). The addition of DPP-4 inhibitors to ongoing insulin ther...